Moody: the works
Essays
Glanglish - with audio versions - new post
Travel writings
Moody's Black Notebook Travels - new post
Novels
open source, open genomics, open creation
Empire's End
or
The Tale of a Tourist
Posted by Glyn Moody at 2:43 pm 0 comments
Labels: canaletto, goldoni, india, lorenzetti, venice, vivaldi
Here on Techdirt we've written a number of times about India's efforts to provide key drugs to its population at prices that they can afford, and how its approach is beginning to spread to other countries. That's a big worry for Western pharma companies, which see their business model of selling medicines at high prices threatened by newly-assertive nations. The latest to join that club is South Africa.
Posted by Glyn Moody at 12:55 pm 0 comments
Labels: big pharma, generics, india, south africa, techdirt
Like many other countries, India has been steadily extending its national surveillance capabilities. We wrote about its main Central Monitoring System (CMS) back in May last year, with more details in July. In news that shocked no one, we discovered in September that illegal surveillance is already taking place. And now, via The Economic Times, we learn that India has built another, completely independent system for spying on its citizens:
Posted by Glyn Moody at 12:35 pm 0 comments
Labels: cms, india, surveillance, techdirt
Techdirt has been reporting for a while on India's growing success in providing its population with access to low-cost generic drugs, making use of the permissions to do so granted by TRIPS. That has naturally earned it the ire of Western pharma companies, which now seem to be striking back, as this post on Infojustice.org explains:
Techdirt has run several stories about the difficulties students in emerging economies have when it comes to buying expensive study materials. Back in 2012, Costa Rican students took to the streets to defend their right to photocopy otherwise unaffordable university textbooks. Earlier this year, Indian textbook authors asked for a lawsuit brought by Western publishers against Delhi University and a nearby photocopying shop over alleged infringements to be dropped. A common element to those two stories is that students often resort to making photocopies of books, since they can't afford the originals. According to this story from Calcutta's The Telegraph, it seems that the Indian government wants to turn the practice into a recognized right:
Posted by Glyn Moody at 10:14 am 0 comments
Labels: copyright, costa rica, delhi, india, techdirt, textbooks
One of the many benefits of Edward Snowden's leaks about NSA spying is that it is flushing out similar activity around the world. Tim Cushing wrote recently about Sweden's illegal snooping, and now The Hindu reveals that India is doing something very similar:
There's a worrying trend around the world for governments to extend online surveillance capabilities to encompass all citizens -- often justified with the usual excuse of combatting terrorism and/or child pornography. The latest to join this unhappy club is India, which has put in place what sounds like a massively intrusive system, as this article from The Times of India makes clear:
Posted by Glyn Moody at 12:22 pm 0 comments
Labels: india, surveillance, techdirt
A few weeks back, we wrote about the Indian Supreme Court's rejection of Novartis's attempt to use "evergreening" to prolong its patent on Gleevec, sold as Glivec in India. That term refers to the trick of making small changes to a drug, usually one about to come off patent, in order to gain a new monopoly that extends its manufacturer's control over a medicine. But how does that work in practice?
Posted by Glyn Moody at 8:26 pm 0 comments
Labels: evergreening, india, patents, pharma, techdirt
Techdirt has been covering the free trade agreement being negotiated between India and the EU for a while now -- that is, as well as anyone can report on something that is being conducted behind closed doors. Despite or maybe even because of that secrecy, one issue in particular has raised concerns: that India's crucial role as supplier of low-cost generics to the world's poor might be under threat. Against that background, this report on the Live Mint site comes as something of a surprise:
One of the many problems with the secretive nature of trade agreements is that it insulates negotiators from the real-world consequences of their actions. That's particularly true for the FTA talks between the EU and India, currently taking place behind closed doors. One of the key issues for the EU side is India's role as a supplier of generic medicines to the world, and India's tough stance on issues like the evergreening of pharma patents. From the various leaks that we have, it seems that the EU is demanding that India toe the line on drug patents, and cut back its supply of low-cost generics to emerging countries.
Back in October last year, we wrote about Costa Rican students taking to the streets to defend their right to photocopy otherwise unaffordable university textbooks. Of course, that's not just a problem in Costa Rica: in many parts of the world, high prices act as a significant barrier to education, and it will come as no surprise that photocopying is an accepted practice in many countries.
Posted by Glyn Moody at 6:25 pm 0 comments
Labels: copyright, costa rica, india, techdirt, university
Back in October last year, in the context of India showing itself increasingly sceptical about pharma patents that drive up drug prices beyond the reach of its citizens, we wrote about an important court battle over Novartis's drug Gleevec, sold as Glivec in India. The definitive judgement from India's Supreme Court was announced today, reported here by The Guardian:
Techdirt has been pointing out for years that more patents is not the same thing as more innovation, even though many around the world would have us believe otherwise. It seems the message is finally getting through: here's a remarkable statement from India on the subject of innovation and small- and medium-sized companies, made at a TRIPS Council meeting:
Posted by Glyn Moody at 3:39 pm 0 comments
Labels: india, innovation, patents, techdirt, trips
Techdirt has been tracking for some time the worrying moves in India that have involved censoring the Twitter accounts of journalists and political groups, or blocking sites. But this bizarre story from the Times of India goes beyond these in a number of ways:
Posted by Glyn Moody at 10:42 pm 0 comments
Labels: censorship, india, techdirt, twitter
Back in March last year, the Indian government announced that it was granting its first compulsory license, for the anti-cancer drug marketed as Nexavar, whose $70,000 per year price-tag put it out of reach of practically everyone in India. Nexavar's manufacturer, the German pharmaceutical giant Bayer, naturally appealed against that decision, and the hearing before the India Intellectual Property Appeals Board (IPAB) has now begun. Jamie Love has provided a useful report on the proceedings; here's his summary of what's at stake:
Posted by Glyn Moody at 11:46 pm 0 comments
Labels: drug patents, india, licensing, techdirt
As Techdirt has reported over the last year, the Indian government is becoming increasingly keen on using cheaper, generic versions of important drugs to treat diseases, rather than paying Western-level prices its people can ill afford. Intellectual Property Watch reports on another instance of the Indian authorities easing the way for low-cost versions by striking down a patent granted to Roche for the treatment of Hepatitis C. As the article explains, it's notable for at least two reasons:
Posted by Glyn Moody at 9:17 pm 0 comments
Labels: drug patents, india, pharma, techdirt
It's fairly widely accepted that the key digital device in the future will be the mobile phone, not the desktop computer that has had such an impact on Western society for the last few decades. That's partly a question of cost -- if devices are to reach even the poorest in emerging economies, they must be very cheap. But there are also other factors, such as the mobile phone's small size and portability; its rugged design and ability to cope with intermittent power supplies; and the built-in Net connectivity that more or less comes as standard.
Posted by Glyn Moody at 4:16 pm 0 comments
Labels: india, mobiles, smartphones, techdirt, women
To the extent possible under law,
glyn moody
has waived all copyright and related or neighbouring rights to
this work.
This work is published from:
United Kingdom.